You are viewing the "Alzheimer’s" Archives
The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial
By: Scott Hensley | Jon Hamilton | Laurel Wamsley | NPR
Posted on:
This is the first new drug approved for Alzheimer’s disease since 2003. It’s the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer’s disease.
Athens Walk to End Alzheimer’s
Join us on Saturday, September 28 at the Athens Community Center for the Alzheimer’s Association’s Walk to End Alzheimer’s®! This is our largest event to raise awareness and funds for Alzheimer’s care, support and research. This inspiring event calls on participants of all ages and abilities to join the fight against the disease! To register… Read More
A Genetic Test That Reveals Alzheimer’s Risk Can Be Cathartic Or Distressing
By: Jon Hamilton | NPR
Posted on:
Genetic tests can now tell us a lot about our risk for developing Alzheimer’s disease. But that doesn’t mean people are prepared to receive the information.
Free workshop on Caregiver Stress
The Athens Village is hosting a free workshop on Caregiver Stress, provided by Fairhope Hospice of Lancaster. An Adult Grief Support Coordinator will speak about techniques for dealing with caregiver stress, and facilitate an open discussion. Snacks will be provided, or bring your own. The workshop will be held at ACEnet Conference Room C (building… Read More
Senators Propose Bill To Develop Alzheimer’s, Dementia Action Plan
By: Karen Kasler | Statehouse News Bureau
Posted on:
Two state senators say Ohio needs to join all other states in developing a comprehensive plan to deal with rising numbers of residents with Alzheimer’s and dementia that are likely in the next few decades. “We have a runaway train coming at us. That train is fueled by demographics,” said Sen. Steve Wilson (R-Maineville). He… Read More
Active Ingredient In Marijuana Reduced Alzheimer’s-Like Effects In Mice
By: Jon Hamilton | NPR
Posted on:
In mice genetically programmed to develop Alzheimer’s symptoms, those given a synthetic version of a chemical in marijuana retained normal memory function.